Nikola warned investors on its third-quarter conference call that the company only had enough cash to support its business into the first quarter of 2025.
Related Posts
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.
Trump will ask Supreme Court for ‘expedited ruling’ on tariffs appeal
A federal appeals court last week ruled most of President Donald Trump’s global tariffs are illegal, undercutting his expansive trade policy.
Elon Musk is $70 billion richer since Trump victory due to Tesla stock surge
Tesla’s 39% surge since Donald Trump’s election victory last week has lifted Elon Musk’s net worth by about $70 billion.